Enquiry/Quote
No Image Available

Lamivudine Zidovudine & Nevirapine Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 150mg + 300mg + 200mg

Reference Brands:

Category: Hepatitis

Lamivudine Nevirapine Zidovudine Tablet is a medicine that is used for the treatment of HIV Infection, Hepatitis B Virus Infection, HIV-1 Infection, HIV Infections and other conditions. Lamivudine Nevirapine Zidovudine Tablet contains Lamivudine, Nevirapine, and Zidovudine as active ingredients.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

๐Ÿ“˜ Sourcing Guide

Product Description: Lamivudine Nevirapine Zidovudine Tablet works by increasing the number of infection fighting cells in the body; stopping the reverse transcriptase from working, thus helps to control HIV-1 infection; blocking the enzyme required for viral growth

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Related Products

Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir

Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)

Form: Tablet

Reference Brands: Viekira Pakยฎ (US); Viekiraxยฎ + Exvieraยฎ (EU)

View Details
Ribavirin

Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL

Form: Tablets, Capsules and Oral Solution

Reference Brands: Rebetolยฎ, Copegusยฎ, Virazoleยฎ(EU & US)

View Details
Adefovir Dipivoxil

Strength:
10 mg

Form: Oral tablets

Reference Brands: Hepseraยฎ (EU & US)

View Details
Tenofovir Alafenamide (Taf)

Strength:
25 mg TAF per tablet

Form: Tablet

Reference Brands: Vemlidy (EU & US), Genvoya (India)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.